Manorama Industries’ board has greenlit a substantial capital expenditure (‘Capex’) plan, earmarking approximately ₹460 crores for the next two to three years. The funds are intended for capacity enhancement, new projects, and infrastructure upgrades. The board also approved key executive re-designations and the reappointment of an independent director, shaping the company’s leadership for future growth.
Significant Capital Expenditure Plan
The board of directors has approved a capital expenditure plan involving an estimated investment of approximately ₹460 crores over the next two to three years. This investment aims to enhance manufacturing capacity, support new projects, improve infrastructure, and facilitate technology upgrades. The funding will be sourced through a mix of internal accruals, debt, equity, and other permissible sources. The actual spending may vary based on project execution and external factors.
Capex Breakdown
The capital expenditure is allocated across several key projects:
- Setting up a manufacturing facility for Cocoa Butter Alternative (CBA) with an input capacity of 75,000 metric tons per year.
- Establishing a new Solvent Fractionation facility for Sal, Shea, Palm, Mango, and other exotic seeds and ESOS, also with a capacity of 75,000 metric tons per year.
- Creating a new Refinery manufacturing facility with a capacity of 90,000 metric tons per year.
- Implementing backward integration through a processing factory in Burkina Faso with a capacity of 90,000 metric tons per year.
The capex plan remains subject to statutory and regulatory approvals and will be implemented in phases based on business needs.
Executive Leadership Changes
The board has approved key changes in executive roles:
- Re-appointment of Mr. Nipun Sumanlal Mehta as an Independent Director for another term of 5 years.
- Re-designation of Mr. Deep Saraf as Deputy Chief Executive Officer – Chief Coordinator.
- Re-designation of Dr. Krishnadath Bhaggan as Deputy Chief Executive Officer – Business Development & Vice President – R&D.
Financial Performance Highlights (Q3 FY26)
Manorama Industries has reported its standalone and consolidated financial results for Q3 FY26 (October-December 2025). Key highlights include:
- Standalone Revenue from Operations: ₹36253.79 lacs compared to ₹20920.47 lacs in Q3 FY25.
- Standalone Net Profit: ₹6824.46 lacs.
- Consolidated Revenue from Operations: ₹37413.53 lacs.
- Consolidated Net Profit: ₹7227.15 lacs.
Source: BSE
